SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
announced that its partner, Pfizer PFE, terminated its global collaboration and license agreement for giroctocogene fitelparvovec, a one-time gene therapy candidate for treating moderately severe to severe hemophilia A. Following Pfizer's decision to end the collaboration, Sangamo regained development and commercialization rights to giroctocogene fitelparvovec. The company is considering all options to continue the program, which includes looking for a new collaboration partner for the candidate. In the year so far, Sangamo's shares have gained 330.7% against the industry's 13.1% decline. Zacks Investment Research Image Source: Zacks Investment Research PFE Returns Rights to SGMO Despite Pivotal Study Meeting Goal A rare genetic blood disorder, hemophilia is caused by a missing clotting protein Factor VIII (FVIII) in hemophilia A, which prevents normal blood clotting. If the blood does not clot properly, it can lead to painful bleeding inside the joints that can cause scar
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Venture fund founder sues PayPal alleging racial discrimination [TechCrunch]TechCrunch
- Pfizer: A Step-By-Step Strategy Before Earnings [Seeking Alpha]Seeking Alpha
- New gun laws in 2025 | The Excerpt [USA TODAY]USA TODAY
- Tesla Stock Dives About 5% As Q4 Vehicle Deliveries Fall Short Of Estimates [Forbes]Forbes
- Got $5,000? These 3 Stocks Are Absurdly Cheap Buys Heading Into 2025 [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- PFE's page on the SEC website